CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Ji Hee Yu, So Young Park, Da Young Lee, Nan Hee Kim, Ji A Seo
Kidney Res Clin Pract. 2022;41(2):136-149.   Published online March 25, 2022
DOI: https://doi.org/10.23876/j.krcp.22.001

Excel Download

GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Ji Hee Yu, So Young Park, Da Young Lee, Nan Hee Kim, Ji A Seo
Kidney Research and Clinical Practice. 2022;41(2):136-149   Crossref logo
Link1 Link2 Link3
GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
Daiji Kawanami, Yuichi Takashi
Frontiers in Pharmacology. 2020;11:   Crossref logo
Link1
GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Physiology to Clinical Outcomes
Alba Rojano Toimil, Andreea Ciudin
Journal of Clinical Medicine. 2021;10(17):3955   Crossref logo
Link1
Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists
Scott Cohen, Hillel Sternlicht, George L. Bakris
Current Diabetes Reports. 2022;22(5):213-218   Crossref logo
Link1 Link2 Link3
Evidence for Cardiorenal Protection with SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Patients with Diabetic Kidney Disease
Panagiotis I. Georgianos, Vasilios Vaios, Stefanos Roumeliotis, Konstantinos Leivaditis, Theodoros Eleftheriadis, Vassilios Liakopoulos
Journal of Personalized Medicine. 2022;12(2):223   Crossref logo
Link1
Addressing screams for evidence on renoprotection by GLP-1 receptor agonists
Takayoshi Sasako, Toshimasa Yamauchi
Kidney International. 2022;101(2):222-224   Crossref logo
Link1 Link2
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives
Riccardo Nevola, Raffaella Epifani, Simona Imbriani, Giovanni Tortorella, Concetta Aprea, Raffaele Galiero, Luca Rinaldi, Raffaele Marfella, Ferdinando Carlo Sasso
International Journal of Molecular Sciences. 2023;24(2):1703   Crossref logo
Link1
Improving management of diabetic kidney disease: will GLP-1 receptor agonists have a role?
Srikanth Bellary, Abd A Tahrani, Anthony H Barnett
The Lancet Diabetes & Endocrinology. 2020;8(11):870-871   Crossref logo
Link1 Link2
Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
Agata Winiarska, Monika Knysak, Katarzyna Nabrdalik, Janusz Gumprecht, Tomasz Stompór
International Journal of Molecular Sciences. 2021;22(19):10822   Crossref logo
Link1
GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art
Antonio Granata, Rosario Maccarrone, Massimiliano Anzaldi, Giuseppe Leonardi, Francesco Pesce, Francesco Amico, Loreto Gesualdo, Salvatore Corrao
Clinical Kidney Journal. 2022;15(9):1657-1665   Crossref logo
Link1 Link2 Link3